TWD 43.6
(-4.7%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Operating Cash Flow | 225.52 Million | 135.21 Million | 18.85 Million | 55.39 Million | - |
Net Income | 30.02 Million | 219.24 Million | 463.22 Million | 24.32 Million | - |
Depreciation & Amortization | 87.48 Million | 109.58 Million | 112.77 Million | 6.16 Million | - |
Deferred income taxes | - | - | - | - | - |
Stock-based compensation | 3.99 Million | 1.51 Million | - | - | - |
Change in working capital | 101.68 Million | -116.57 Million | -614.98 Million | 14.42 Million | - |
Other non-cash items | -4.25 Million | -818 Thousand | -116 Thousand | -2.52 Million | - |
Investing Cash Flow | -305.84 Million | 54.6 Million | 251.72 Million | -215.08 Million | - |
Investments in PPE | -308.67 Million | -38.79 Million | -36.2 Million | -18.78 Million | - |
Acquisitions | 409 Thousand | - | -3.62 Million | 67.88 Million | 934 Thousand |
Investment purchases | - | - | - | -267.85 Million | - |
Sales/Maturities of investments | - | 45.19 Million | 267.85 Million | - | - |
Other Investing Activities | 2.51 Million | -1.45 Million | 23.69 Million | 3.66 Million | - |
Financing Cash Flow | 94.47 Million | -204.61 Million | -9.04 Million | 713.43 Million | - |
Debt repayment | -189.33 Million | - | - | -254 Thousand | - |
Dividends payments | -72.46 Million | -175.7 Million | - | - | - |
Common Stock Repurchased | - | - | - | - | - |
Common Stock Issuance | - | - | - | 735.93 Million | - |
Other Financing Activities | 93 Thousand | - | - | -13.28 Million | 13.84 Million |
Accounts receivables | 158.93 Million | - | - | - | - |
Accounts payables | -33.22 Million | - | - | - | - |
Inventory | 88.23 Million | -13.77 Million | -11.68 Million | 6.49 Million | - |
Other working capital | -145.47 Million | - | - | - | - |
Cash at beginning of period | 852.9 Million | 847.24 Million | 589.32 Million | 38.33 Million | - |
Cash at end of period | 856.76 Million | 852.9 Million | 847.24 Million | 589.32 Million | - |
Capital Expenditure | -308.67 Million | -38.79 Million | -36.2 Million | -18.78 Million | - |
Effect of forex changes on cash | -10.3 Million | 20.45 Million | -3.6 Million | -2.75 Million | - |
Net cash flow / Change in cash | 3.85 Million | 5.66 Million | 257.91 Million | 550.98 Million | - |
Free Cash Flow | -83.14 Million | 96.42 Million | -17.35 Million | 36.6 Million | - |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 105.34 Million | -60.51 Million | 30.02 Million | -33.89 Million | 75.19 Million | 59.64 Million |
Depreciation & Amortization | 23.25 Million | 22.81 Million | 87.48 Million | 21.97 Million | 21.89 Million | 21.7 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | 2.65 Million | 694 Thousand | 3.99 Million | 1.42 Million | 1.2 Million | 704 Thousand |
Change in working capital | -220.51 Million | 9.26 Million | 101.68 Million | 90.31 Million | 76.19 Million | -160.57 Million |
Other non-cash items | -5.94 Million | -5 Million | -4.25 Million | -4.09 Million | 1000.00 | 86 Thousand |
Investing Cash Flow | -6.96 Million | -8.67 Million | -305.84 Million | -1.12 Million | -13.23 Million | -23.25 Million |
Investments in PPE | -7.16 Million | -7.51 Million | -308.67 Million | -3.08 Million | -12.64 Million | -23.52 Million |
Acquisitions | 12 Thousand | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | 185 Thousand | -2.04 Million | 2.51 Million | 1.64 Million | -588 Thousand | 273 Thousand |
Financing Cash Flow | -10.33 Million | -10.26 Million | 94.47 Million | -9.67 Million | -81.96 Million | 191.77 Million |
Debt repayment | -3.99 Million | -3.99 Million | -189.33 Million | -3.99 Million | -3.99 Million | -197.33 Million |
Dividends payments | - | - | -72.46 Million | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -6.33 Million | - | 93 Thousand | - | - | - |
Accounts receivables | -298.63 Million | - | - | - | - | - |
Accounts payables | 51.91 Million | - | - | - | - | - |
Inventory | -28.28 Million | -54.22 Million | 88.23 Million | 57.48 Million | 75.59 Million | -38.29 Million |
Other working capital | 49.59 Million | - | - | - | - | - |
Cash at beginning of period | 847.95 Million | 856.76 Million | 852.9 Million | 857.75 Million | 731.09 Million | 637.14 Million |
Cash at end of period | 749.35 Million | 847.95 Million | 856.76 Million | 856.76 Million | 857.75 Million | 731.09 Million |
Capital Expenditure | -7.16 Million | -7.51 Million | -308.67 Million | -3.08 Million | -12.64 Million | -23.52 Million |
Effect of forex changes on cash | 13.3 Million | 35.95 Million | -10.3 Million | -40.65 Million | 44.46 Million | -14.37 Million |
Net cash flow / Change in cash | -98.6 Million | -8.81 Million | 3.85 Million | -991 Thousand | 126.65 Million | 93.95 Million |
Free Cash Flow | -101.77 Million | -33.35 Million | -83.14 Million | 47.37 Million | 164.74 Million | -83.72 Million |
8464
BACTI-B
GNE
FMCCT
2136
HPURF